PKBDO3621OPMO
PKBDO3621OPMO
released
Clinical summary
Diabetes status
Control Without Diabetes
BMI
23.9
HbA1c %
5.9
C-Peptide (ng/ml)
22.12
Diabetes duration
-
Demographics
- Age (y)
- 20.04
- Gender
- Male
- Ethnicity
- Hispanic
Additional clinical
- Diabetes (ontology)
- No ontology term
- T1D stage
- At-risk: single or transient autoantibody, normal glucose level
- Derived diabetes status
- Prediabetes
- Living donor
- No
- Cause of death
- Head Trauma
- Hospital stay (h)
- 84
Autoantibodies
GADAPositive
No value
1
IAANegative
No value
IA2Negative
No value
ZNT8Negative
No value
HLA typing
| Locus | Allele 1 | Allele 2 | Method |
|---|---|---|---|
| A | 02:01 | 24:02 | NGS |
| B | 13:02 | 51:01 | NGS |
| C | 06:02 | 15:02 | NGS |
| DRB1 | 07:01 | 11:01 | NGS |
| DQA1 | 02:01 | 05:05 | NGS |
| DQB1 | 02:02 | 03:01 | NGS |
| DPA1 | 01:03 | 01:03 | NGS |
| DPB1 | 02:01 | 04:01 | NGS |
Supplementary
nPOD
nPOD_portal:6532
- Pancreas tissue available
- Yes
- Other tissues
- —
Attribution
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
